SCHEMBL6089793

SCHEMBL6089793

CCc1c(Sc2cc(C)cc(C)c2)n(Cc2nc3ccccc3o2)c(=O)[nH]c1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.38
PIK3CD O00329 1/20 0.36
PIK3CB P42338 1/20 0.36
KMT2A Q03164 4/20 0.36
ALDH1A1 P00352 3/20 0.36
MAPT P10636 2/20 0.36
MEN1 O00255 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
AKR1B1 P15121 1/20 0.35
HCRTR2 O43614 1/20 0.35
TSHR P16473 3/20 0.34
MAPK1 P28482 3/20 0.34
HPGD P15428 3/20 0.34
USP2 O75604 2/20 0.34
HSD17B10 Q99714 2/20 0.34
NPC1 O15118 1/20 0.34
TP53 P04637 2/20 0.34
LMNA P02545 2/20 0.34
DPP4 P27487 1/20 0.34
CNR2 P34972 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6086306 0.86 KMT2A (0.39) RAB9APIK3CDPIK3CBKMT2AALDH1A1
SCHEMBL7836075 0.85 RAB9A (0.38) RAB9APIK3CDPIK3CBKMT2AALDH1A1
SCHEMBL6086262 0.81 TP53 (0.39) RAB9APIK3CDPIK3CBKMT2AMAPT
SCHEMBL6087657 0.81 TP53 (0.39) RAB9APIK3CDPIK3CBKMT2AALDH1A1
SCHEMBL6086514 0.81 PDE10A (0.40) KMT2AALDH1A1MEN1TSHRMAPK1
SCHEMBL6086545 0.81 HPGD (0.43) KMT2AALDH1A1MEN1TSHRMAPK1
SCHEMBL6086995 0.78 POLB (0.35) KMT2AALDH1A1MEN1SMN1; SMN2TSHR
SCHEMBL6086609 0.77 GRIN1 (0.45) KMT2AMEN1TSHRMAPK1LMNA
SCHEMBL6086507 0.77 DAO (0.45) KMT2AALDH1A1MEN1SMN1; SMN2TSHR
SCHEMBL6087421 0.77 SMN1; SMN2 (0.37) KMT2AALDH1A1MEN1SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6987114-B1 Antiviral pyrimidinedione derivatives and process for the preparation thereof SAMJIN PHARMACEUTICAL CO., LTD (KR) 2006-01-17 US disclosed